itraconazole and micafungin

itraconazole has been researched along with micafungin in 80 studies

Research

Studies (80)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's46 (57.50)29.6817
2010's31 (38.75)24.3611
2020's3 (3.75)2.80

Authors

AuthorsStudies
Clemons, KV; Luque, JC; Stevens, DA1
Denning, DW; Morrissey, G; Morrissey, J; Warn, PA1
Yamaguchi, H1
Du Toit, A; Esterhuizen, K; Jacobs, P; Wood, L1
Ikeda, F1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S1
Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K1
Denning, DW; Guinea, J; Sharp, A; Warn, PA1
Maruyama, T; Takagi, T; Yuda, H1
Steinbach, WJ1
Niwa, T; Shiraga, T; Takagi, A1
Fujita, J; Furugen, M; Haranaga, S; Higa, F; Saitou, A; Shinzato, T; Shiroma, R; Tateyama, M; Touyama, M; Yara, S1
Endo, H; Kondo, H; Kume, H; Nomura, T; Yoshida, H1
Abe, N; Azuma, T; Hatta, K; Ishimaru, H; Komatsu, M; Okamoto, M1
Fujihara, M; Fujita, Y; Iwato, K; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T1
Clemons, KV; Stevens, DA1
Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K1
Fujii, M; Kato, M; Kawabata, A; Sugino, Y; Yagi, A1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Chihara, K; Fujiwara, K; Yamashina, A1
Maesaki, S2
Homma, S; Izumikawa, K; Kawabata, M; Kishi, K; Miyamoto, A; Ohtsu, Y; Sakamoto, S; Takaya, H; Tsuboi, E; Yoshimura, K1
Adachi, M; Andou, K; Hirose, T; Horichi, N; Hosaka, T; Ishida, H; Kusumoto, S; Nakashima, M; Ohnishi, T; Okuda, K; Shirai, K; Sugiyama, H; Yamaoka, T1
Hashinaga, K; Hiramatsu, K; Ishii, H; Iwata, A; Kadota, J; Kishi, K; Kohno, K; Kushima, H; Ogata, M; Ohama, M; Saikawa, T; Tokimatsu, I; Umeki, K1
Carrillo, AJ; Guarro, J; Mariné, M; Pastor, J; Quindós, G; Serena, C1
Aihara, K; Fukui, M; Ishitoko, M; Itotani, R; Kagioka, H; Matsumoto, M; Suzuki, S; Takemura, M1
Guarro, J; Mariné, M; Pastor, FJ; Rodriguez, MM; Ruíz-Cendoya, M1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L1
Fujii, Y; Inase, N; Yoshizawa, Y1
Gabazza, EC; Maruyama, T; Morser, J; Taguchi, O; Takei, Y1
Kato, T; Ohnishi, R; Sano, K; Suzuki, T; Yasuda, S1
Denning, DW; Morrissey, G; Sharp, A; Warn, PA1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA1
Iwashima, Y; Morita, H; Nakamura, A; Oguri, T; Sato, S; Uemura, T1
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K1
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M1
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K1
Chen, H; Chen, X; Han, M; Hu, J; Huang, H; Huang, X; Lai, Y; Liu, T; Wang, J; Wu, D; Zhu, H; Zou, P1
Mikamo, H; Mochizuki, K; Murase, H; Suematsu, H; Yamagishi, Y; Yasuda, Y1
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L1
Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S1
Yoshida, M1
Furuya, N; Mano, Y; Morishige, H; Oguri, T1
Ishibashi, Y; Kobayashi, A; Oikawa, Y; Sugiyama, K; Tokoro, M; Yamazaki, N; Yokogawa, H1
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA1
Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K1
Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J1
Hishiya, N; Kasahara, K; Maeda, K; Matsumoto, K; Mikasa, K; Morita, K; Nario, K; Ogawa, T; Tsujimoto, K; Uno, K; Yamada, Y1
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF1
Choi, CW; Jang, JH; Jeong, SH; Kim, DY; Kim, JS; Kim, SH; Mun, YC; Park, JS1
Al-Hatmi, AM; Bonifaz, A; Curfs-Breuker, I; De Hoog, GS; Meis, JF; Meletiadis, J1
Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ1
Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H1
Hsueh, PR; Wang, H; Xu, YC1
Almeida-Paes, R; Barbedo, LS; de Oliveira, JCA; Dos Santos, ALS; Figueiredo-Carvalho, MHG; Ramos, LS; Zancopé-Oliveira, RM1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E1
Fujita, H; Fujiwara, SI; Fukuda, T; Gotoh, M; Iino, M; Jo, Y; Kanda, Y; Kimura, SI; Matsumura, I; Nakamura, S; Okamoto, A; Oyake, T; Saburi, Y; Sakaida, E; Shiratori, S; Takamatsu, Y; Tamura, K; Yamaguchi, H; Yamanouchi, J1
Liang, G; Liu, M; Liu, W; Zeng, R; Zheng, H; Zheng, N1
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C1
Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL2
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chu, CC; Hsueh, PR; Ruan, SY1
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Müller, FM; Salvenmoser, S; Seidler, MJ1
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL1
Dimopoulos, G; Falagas, ME; Velegraki, A1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE1
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1

Reviews

13 review(s) available for itraconazole and micafungin

ArticleYear
[Antifungal drug].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fluorouracil; Fungi; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Polyenes; Pyrimidines

2003
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
[Drug-drug interaction of antifungal drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:10

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
[The future of antifungal agents].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2007
[New development in the treatment of deep-seated mycoses].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Sep-10, Volume: 96, Issue:9

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Treatment of invasive candidal infections: systematic review and meta-analysis.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
[Clinical efficacies of antifungal injections].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2008
Traditional and emerging antifungal therapies.
    Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2010
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2012
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:2

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole

2016
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Future microbiology, 2016, Volume: 11

    Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole

2016
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Trials

4 trial(s) available for itraconazole and micafungin

ArticleYear
The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome

2012
Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:10

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Treatment Outcome

2012
Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
    Annals of hematology, 2016, Volume: 95, Issue:2

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Echinocandins; Empirical Research; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Itraconazole; Length of Stay; Lipopeptides; Male; Micafungin; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult

2016
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 03-10, Volume: 38, Issue:8

    Topics: Adult; Aged; Antifungal Agents; Febrile Neutropenia; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukocyte Count; Male; Micafungin; Middle Aged; Mycoses; Neutrophils; Young Adult

2020

Other Studies

63 other study(ies) available for itraconazole and micafungin

ArticleYear
Efficacy of micafungin alone or in combination against systemic murine aspergillosis.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Female; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic

2003
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Colony Count, Microbial; Drug Resistance, Fungal; Echinocandins; Immunosuppressive Agents; Itraconazole; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic

2003
Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Drug Evaluation; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Mucormycosis; Multiple Organ Failure; Peptides, Cyclic; Periodontal Abscess; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sinusitis; Splenectomy; Systemic Inflammatory Response Syndrome; Transplantation, Homologous

2003
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:4

    Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic

2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors

2003
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Echinocandins; Gases; Hypoxia; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Oxygen; Peptides, Cyclic

2004
[Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2005, Volume: 43, Issue:2

    Topics: Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Female; Humans; Infusions, Intravenous; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Treatment Outcome

2005
[Two cases of pulmonary aspergillosis successfully treated with combinated micafungin and itraconazole therapy].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2005, Volume: 79, Issue:12

    Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Tomography, X-Ray Computed

2005
[Combined effect of micafangin and itraconazole on severe aspergillosis of the bilateral pleural cavities in a patient with Wegener's granulomatosis].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2006, Volume: 47, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillosis; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Granulomatosis with Polyangiitis; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Peptides, Cyclic; Pleural Cavity

2006
[Successful treatment of invasive sinus aspergillosis with micafungin and itraconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2006, Volume: 80, Issue:2

    Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cavernous Sinus; Combined Modality Therapy; Echinocandins; Ethmoid Sinusitis; Female; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Orbit; Peptides, Cyclic; Sinusitis; Sphenoid Sinusitis

2006
Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2006, Volume: 64, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Debridement; DNA, Fungal; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Lipoproteins; Lymphoma, Non-Hodgkin; Male; Maxillary Diseases; Maxillary Sinus; Micafungin; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Renal Insufficiency; Sinusitis; Treatment Outcome

2006
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
    Medical mycology, 2006, Volume: 44, Issue:1

    Topics: Aminoglycosides; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Antagonism; Drug Therapy, Combination; Echinocandins; Female; Immunosuppression Therapy; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Micafungin; Mice; Mice, Inbred DBA; Peptides, Cyclic; Survival Analysis

2006
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Biochemical and biophysical research communications, 2006, Aug-25, Volume: 347, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity

2006
[Micafungin therapy for a case of chronic necrotizing pulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Necrosis; Peptides, Cyclic

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
[Preoperative antifungal agent for pulmonary aspergilloma].
    Kyobu geka. The Japanese journal of thoracic surgery, 2006, Volume: 59, Issue:13

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Echinocandins; Humans; Infusions, Intravenous; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Pneumonectomy; Treatment Outcome

2006
Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Medical mycology, 2007, Volume: 45, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Radiography; Retrospective Studies; Treatment Outcome

2007
[Two cases of successfully treated invasive pulmonary aspergillosis following influenza virus infection].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:4

    Topics: Aged; Alphainfluenzavirus; Amphotericin B; Antifungal Agents; Aspergillosis; Betainfluenzavirus; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Female; Humans; Influenza, Human; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Peptides, Cyclic

2007
Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:11

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Sputum; Stem Cell Transplantation

2007
In vitro activity of micafungin combined with itraconazole against Candida spp.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:5

    Topics: Antifungal Agents; Candida; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests

2007
[Case of bronchocentric granulomatosis that became recognized in the course of allergic bronchopulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:6

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bronchial Diseases; Clarithromycin; Drug Therapy, Combination; Echinocandins; Granuloma; Humans; Itraconazole; Lipopeptides; Lipoproteins; Macrolides; Male; Methylprednisolone; Micafungin; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome

2008
In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:5

    Topics: Antifungal Agents; Drug Synergism; Echinocandins; Fungi; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Quality Control

2008
Different bile concentration of micafungin and itraconazole in a patient with candidal cholecystitis.
    The Journal of infection, 2009, Volume: 58, Issue:4

    Topics: Aged, 80 and over; Antifungal Agents; Bile; Candidiasis; Cholecystitis; Echinocandins; Esophageal Neoplasms; Humans; Itraconazole; Lipopeptides; Male; Micafungin

2009
[Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Pulmonary Aspergillosis

2009
Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:2

    Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Injections, Intraperitoneal; Injections, Intravenous; Itraconazole; Kidney; Lipopeptides; Liver; Male; Micafungin; Mice; Survival Analysis; Treatment Outcome

2010
[Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:11

    Topics: Aged; Antibodies, Fungal; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Eosinophils; Humans; Immunoglobulin E; Invasive Pulmonary Aspergillosis; Itraconazole; Leukocyte Count; Lipopeptides; Male; Micafungin; Treatment Outcome

2010
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts

2011
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2012
Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:5

    Topics: Aged; Antifungal Agents; beta-Glucans; Candida tropicalis; Candidiasis; Echinocandins; Endophthalmitis; Female; Fundus Oculi; Humans; Itraconazole; Lipopeptides; Micafungin

2012
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2012, Volume: 86, Issue:2 Suppl 4

    Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices

2012
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
In vivo laser confocal microscopy findings of radial keratoneuritis in patients with early stage Acanthamoeba keratitis.
    Ophthalmology, 2013, Volume: 120, Issue:7

    Topics: Acanthamoeba Keratitis; Adolescent; Adult; Antifungal Agents; Chlorhexidine; Contact Lenses, Hydrophilic; Cornea; Cranial Nerve Diseases; Debridement; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microscopy, Confocal; Neuritis; Ophthalmic Nerve; Prospective Studies; Risk Factors; Young Adult

2013
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
    BMC oral health, 2014, Feb-20, Volume: 14

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia

2014
Antifungal susceptibility of Candida isolates at one institution.
    Medical mycology journal, 2014, Volume: 55, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole

2014
Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Micafungin; Paranasal Sinus Diseases; Radiography

2015
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole

2015
In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:4

    Topics: Antifungal Agents; Dermatomycoses; Drug Combinations; Drug Interactions; Drug Synergism; Echinocandins; Fusariosis; Fusarium; Itraconazole; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole

2016
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole

2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult

2016
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of
    Mediators of inflammation, 2017, Volume: 2017

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Hydrolysis; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Virulence

2017
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult

2019
Effects of Itraconazole and Micafungin on Aspergillus fumigatus Biofilms.
    Mycopathologia, 2021, Volume: 186, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Micafungin; Microbial Sensitivity Tests

2021
In vitro antifungal susceptibilities of five species of sporothrix.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis

2008
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin

2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Susceptibility testing and molecular classification of Paecilomyces spp.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny

2008
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections

2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged

2008
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology

2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies

2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain

2009
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny

2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia

2009
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence

2010
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole

2010